HBM BioCapital

Overview

HBM BioCapital is a Swiss venture capital firm specializing in healthcare and life sciences investments. The firm focuses on development-stage, growth, and buy-out financings of private companies, as well as investments in public companies within the biopharma, medtech, diagnostics, and healthcare sectors. HBM BioCapital is managed by HBM Partners AG, a globally active and independent healthcare-focused investment advisor with over USD 2.4 billion in assets under management. The firm advises several public and private equity investment funds, including HBM Healthcare Investments and HBM BioCapital I & II. HBM BioCapital's investment strategy targets companies in Europe, North America, and Asia-Pacific, with a particular emphasis on Switzerland, the United States, India, China, and other emerging markets. The firm's portfolio includes a diverse range of companies across various stages of development, from seed to pre-IPO, and spans multiple industries within the healthcare and life sciences sectors. HBM BioCapital's team of experienced professionals sources, analyzes, and engages in private and public healthcare investments, supporting the growth of portfolio companies through all stages of development and leveraging its extensive industry network to add value. The firm's investment preferences include equity financing with investments typically ranging between USD 5 million and USD 50 million. HBM BioCapital's track record includes over 100 investments resulting in more than 60 trade sales and IPOs, demonstrating significant value creation and a strong commitment to supporting entrepreneurial biopharma and healthcare companies. The firm's investment philosophy centers on identifying and nurturing innovative companies that have the potential to make a meaningful impact in the healthcare and life sciences sectors, providing them with the resources and expertise needed to achieve sustainable growth and success. HBM BioCapital's approach combines financial acumen with a deep understanding of the healthcare industry, enabling it to effectively support the development and commercialization of groundbreaking therapies, medical devices, diagnostics, and other healthcare innovations. The firm's global presence and extensive network allow it to identify and capitalize on investment opportunities across diverse markets, ensuring a well-balanced and diversified portfolio that aligns with its strategic objectives and investment criteria. HBM BioCapital's commitment to excellence and its proactive approach to portfolio management have established it as a trusted partner for healthcare entrepreneurs and a significant player in the venture capital landscape. The firm's ongoing success is a testament to its dedication to fostering innovation, driving growth, and delivering value to its investors and portfolio companies alike.

Investment Focus

• Equity Financing
• Investment Size: USD 5-50 million
• Geographical Focus: Europe, North America, Asia-Pacific
• Sectors: Biopharma, Medtech, Diagnostics, Healthcare
• Stages: Seed, Early Stage, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed

Portfolio Companies